Page last updated: 2024-11-04

sb 202190 and Carcinoma, Hepatocellular

sb 202190 has been researched along with Carcinoma, Hepatocellular in 5 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"Our findings demonstrated the potential of genipin in suppressing hepatocellular carcinoma metastasis, and p38/TIMP-1/MMP-2 pathway may be involved as the key mechanism of its anti-metastasis effect."7.78Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma. ( Feng, Y; Man, K; Tsao, SW; Wang, N; Zhang, Z; Zhu, M, 2012)
"Our findings demonstrated the potential of genipin in suppressing hepatocellular carcinoma metastasis, and p38/TIMP-1/MMP-2 pathway may be involved as the key mechanism of its anti-metastasis effect."3.78Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma. ( Feng, Y; Man, K; Tsao, SW; Wang, N; Zhang, Z; Zhu, M, 2012)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Refolo, MG1
D'Alessandro, R1
Lippolis, C1
Messa, C1
Carella, N1
Cavallini, A1
Carr, BI1
Wang, N1
Zhu, M1
Tsao, SW1
Man, K1
Zhang, Z1
Feng, Y1
Burlando, B1
Magnelli, V1
Panfoli, I1
Berti, E1
Viarengo, A1
Quan, H1
Xu, Y1
Lou, L1
Bode, JG1
Ludwig, S1
Freitas, CA1
Schaper, F1
Ruhl, M1
Melmed, S1
Heinrich, PC1
Häussinger, D1

Other Studies

5 other studies available for sb 202190 and Carcinoma, Hepatocellular

ArticleYear
Modulation of Doxorubicin mediated growth inhibition of hepatocellular carcinoma cells by platelet lysates.
    Anti-cancer agents in medicinal chemistry, 2014, Volume: 14, Issue:8

    Topics: Antibiotics, Antineoplastic; Apoptosis; Autophagy; Blood Platelets; Carcinoma, Hepatocellular; Cell

2014
Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cholagogues and Choleretics; Do

2012
Ligand-independent tyrosine kinase signalling in RTH 149 trout hepatoma cells: comparison among heavy metals and pro-oxidants.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2003, Volume: 13, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cop

2003
p38 MAPK, but not ERK1/2, is critically involved in the cytotoxicity of the novel vascular disrupting agent combretastatin A4.
    International journal of cancer, 2008, Apr-15, Volume: 122, Issue:8

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Hepatocell

2008
The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription.
    Biological chemistry, 2001, Volume: 382, Issue:10

    Topics: Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Hepatocellular; DNA-Binding Proteins; Enzym

2001